8th WORLD CONGRESS ON HEART FAILURE: MECHANISMS AND MANAGEMENT

Cardiology Online

Home

Welcome

Scientific Committees

Opening Lectures

International Academy
Of Cardiology Awards

Acknowledgements

Timetable

Participant Letter

Final Scientific Program

Instructions for the Preparation of Posters

Writing Instruction
& Sending your Article(s) to the Proceeding Book

Please fill out this form carefully:

Fields marked with (*) are required.

Characters other than English letters, numbers or
punctuation cannot be accepted by this website.

POLICY STATEMENT
The International Academy of Cardiology requires that audiences
at the Academy's educational programs be informed of a presenter's (moderators, speakers, faculty, authors and contributors) academic and professional affiliations, as well as other commercial relationships relevant to the content of the material that is presented.

The policy allows the listener/attendee to be fully informed in evaluating
the information being presented.

The situations may include, but are not limited to
1) stock options or bond holdings in a for-profit corporation or
self-directed pension plan, 2) research grants, 3) employment (full or
part time), 4) ownership or partnership, 5) consulting fees or other
remuneration received by the presenter or his/her immediate family, including support that may be provided to attend the educational meeting, 6) nonremunerative positions of influence such as officer, board member, trustee, or public spokesperson. The disclosure will be shown as an indication (by an *)
for those presenters who have stated that a relationship(s) exists relevant to the topic(s) being discussed.

Indicate any author(s) who has a possible conflict of interest
(see policy statement) by an asterisk (*) next to that author(s) name in the heading of the abstract.

PRESENTING AUTHOR'S PERSONAL DETAILS:

Family name / Surname:(*)

First name and middle initial(s):(*)

Title:

Mailing Address

Position:
complete this field only if it is part of your mailing address

Institution/Organization:
complete this field only if it is part of your mailing address

Department:
complete this field only if it is part of your mailing address

Address:(*)

City:(*)

State:

Country:(*)

Postal code:(*)

Work Phone (office hours): (*)
Country code/city code/number

Home Phone
Country code/city code/number

Fax:
Country code/city code/number

E-mail address:(*)

PREFERRED PRESENTATION TYPE (*)

Oral presentation

Poster presentation

Oral / Poster presentation

For invited faculty members only

This is the abstract of my invited presentation

AUTHOR AFFILIATION (*)

Please list ALL author(s) institution affiliations, in order to refer to
them by their number later (see below).

The authors must also include the following:
Institution, City, State, Country (i.e., Columbia University, New York, NY, USA)

1.
2.
3.
4.
5.
6.
7.
8.
9.
10.

AUTHORS (*)

Please list all authors in the order they should appear in the publication.

In the affiliation field please enter the number
corresponding to the city and country listed above (e.g.: 1).

Please choose only ONE presenting author.

1
	First and middle initial(s)	Family name / Surname	Affiliation numbers	Presenting Author
2
	First and middle initial(s)	Family name / Surname	Affiliation numbers	Presenting Author
3
	First and middle initial(s)	Family name / Surname	Affiliation numbers	Presenting Author
4
	First and middle initial(s)	Family name / Surname	Affiliation numbers	Presenting Author
5
	First and middle initial(s)	Family name / Surname	Affiliation numbers	Presenting Author
6
	First and middle initial(s)	Family name / Surname	Affiliation numbers	Presenting Author
7
	First and middle initial(s)	Family name / Surname	Affiliation numbers	Presenting Author
8
	First and middle initial(s)	Family name / Surname	Affiliation numbers	Presenting Author
9
	First and middle initial(s)	Family name / Surname	Affiliation numbers	Presenting Author
10
	First and middle initial(s)	Family name / Surname	Affiliation numbers	Presenting Author

ABSTRACT CATEGORY(*)

Select one category, under which your abstract will be reviewed:

1. Molecular biology and biochemical aspects of heart failure
2. Vascular biology, endothelial function
3. Apoptosis in vascular and cardiac remodeling
4. Genetic studies in cardiomyopathy
5. Gene transfer therapy in heart failure
6. Growth control and cytokines in vascular cells
7. Natriuretic peptides in heart failure
8. Endothelin in heart failure
9. Pharmacologic modulation of vascular-endothelial function
10. Neurohumoral, immunologic aspects of heart failure
11. Nitric oxide and nitric oxide synthase in heart failure
12. Inflammatory mediators in heart failure
13. Myocyte and receptor abnormalities in heart failure
14. Echocardiography: Contrast, TEE and 3D
15. Nuclear cardiology: myocardial perfusion, function and viability
16. PET / MRI / CT
17. Intracoronary flow, doppler measurements
18. Heart failure due to coronary artery disease
19. Myocardial stunning, hibernation and preconditioning
20. Acute myocardial infarction: thrombolysis and reperfusion
21. Interventional cardiology in acute infarction and angina
22. Antithrombotic and antiplatelet adjunctive therapy for PTCA
23. Blockage of tissue proliferation after coronary interventions
24. Left ventricular remodeling after myocardial infarction
25. Secondary prevention of coronary artery disease
26. Hypertension and heart failure, new therapeutic approaches
27. Heart failure in women
28. Dilated cardiomyopathy: various etiologies
29. Ischemic cardiomyopathy
30. Left ventricular hypertrophy
31. Hypertrophic cardiomyopathy
32. Role of the pericardium
33. Heart failure in valvular heart disease
34. Pulmonary circulation aspects, pulmonary hypertension
35. Heart failure in systemic disease
36. Heart failure in infancy and childhood
37. Preventative aspects of heart failure
38. Prognostic aspects of heart failure
39. Predictors and markers of heart failure outcome
40. Exercise physiology and rehabilitation in heart failure
41. Nursing aspects of heart failure
42. Epidemiology of heart failure
43. Renal aspects - diuretics
44. Digoxin and other new inotropic agents in heart failure
45. Organic nitrates - their role in heart failure management
46. ACE inhibitors and Angiotensin - II receptor blockers
47. Beta-blockers and beta-adrenergic receptors in heart failure
48. Calcium channel blockers and promoters in heart failure
49. Results of major clinical trials
50. Arrhythmias mechanisms and antiarrhythmic drug therapy
51. Sudden death in heart failure
52. Internal defibrillation and implantable antiarrhythmic devices
53. Cardiac pacing strategies in heart failure
54. Advances in congenital heart disease
55. Surgical revascularization: minimally invasive surgery, TMLR
56. Issues surrounding heart valve surgery
57. Mechanical support, left ventricular assist devices
58. Surgery for LV dysfunction
59. Cardiac transplantation
60. Practice guidelines, cost containment
61. Miscellaneous

Please select:

ABSTRACT TITLE (*)

Please enter the title in UPPERCASE:

Abstract Body: (*)

Please note:

Symbols, Sub and Super Script cannot be used in
this form. Symbols may be written in full (e.g. alpha, beta).

Characters other than English letters, numbers or punctuation
cannot be accepted by this website.

The abstract text should not exceed 250 words.

EQUIPMENT:

Click inside the box to select a preferred equipment type.
Use the Ctrl key while clicking in order to select more than one option.
Equipment for Poster Presentations is not available.

PLEASE NOTE: After submitting abstract, you will see an
on-screen message "...your registration has been received"
and a reference number will be given to you.
This indicates your abstract has entered the system for processing.

Please press the "Submit" button ONCE only.